Avilés Agustin
Oncology Research Unit. Oncology Hospital National Medical Center, IMSS, México DF, Mexico.
Mediterr J Hematol Infect Dis. 2015 Sep 1;7(1):e2015052. doi: 10.4084/MJHID.2015.052. eCollection 2015.
Nasal natural killer/T-cell lymphoma (nasal NKTCL), is a rare presentation of extranodal lymphoma in North-America and Europe, but in some countries, as China and Korea, nasal NKTCL occurred in 20 to 46 % of T-cell lymphomas. Some studies, analyzing the incidence in Latin-America, observed some differences between the various populations. However, this comparison included Argentina and Chile, Peru, and other Latin-America but not the Mexico. Thus, we performed a retrospective analysis of the patients diagnosed and treated as nasal, NKTCL, in our institution that is an academic tertiary national reference hospital of Mexico. From 1988 to 2014, we diagnosed and treated 14,816 cases of non-Hodgkin's lymphoma, 10,957 (73%) were of B-cell histology and 3822 (26%) were of T-cell histology. Nasal, NKTCL, was the most frequent of the T-cell histology: 40%. We compared our results with those of other countries and observed that nasal, NKTCL have a small number of cases in North-America, and in some countries of Latin-America, as Argentina, Brazil, and Chile. However, the number of NKTCL cases found in Mexico was similar to that found in Guatemala and Peru, and also in China and Korea. Our study suggests that this neoplasm could have a racial basis, but environmental factors should also be considered.
鼻型自然杀伤/T细胞淋巴瘤(鼻型NKTCL),在北美和欧洲是一种罕见的结外淋巴瘤表现形式,但在一些国家,如中国和韩国,鼻型NKTCL在T细胞淋巴瘤中占20%至46%。一些分析拉丁美洲发病率的研究,观察到不同人群之间存在一些差异。然而,这种比较包括了阿根廷、智利、秘鲁以及其他拉丁美洲国家,但未包括墨西哥。因此,我们对在我们机构(墨西哥一家学术性三级国家转诊医院)被诊断和治疗为鼻型NKTCL的患者进行了回顾性分析。1988年至2014年,我们诊断和治疗了14816例非霍奇金淋巴瘤病例,其中10957例(73%)为B细胞组织学类型,3822例(26%)为T细胞组织学类型。鼻型NKTCL是T细胞组织学类型中最常见的:占40%。我们将我们的结果与其他国家的结果进行了比较,发现鼻型NKTCL在北美以及拉丁美洲的一些国家,如阿根廷、巴西和智利,病例数较少。然而,在墨西哥发现的NKTCL病例数与在危地马拉和秘鲁以及中国和韩国发现的病例数相似。我们的研究表明,这种肿瘤可能有种族基础,但也应考虑环境因素。